Product
CMVpp65 Specific T-cells
1 clinical trial
2 indications
Indication
Cytomegalovirus InfectionIndication
Cytomegalovirus ViremiaClinical trial
A Phase II Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2024-06-01